Identification of PBMC-expressed miRNAs for rheumatoid arthritis

References

• O’shea JJ, Laurence A, Mcinnes IB. Back to the future: oral targeted therapy for RA and other autoimmune diseases. Nat Rev Rheumatol. 2013;9:173–182.
   PubMed Web of Science ®Google Scholar
• Arend WP, Firestein GS. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol. 2012;8:573–586.
   PubMed Web of Science ®Google Scholar
• Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. 2013;9:141–153.
   PubMed Web of Science ®Google Scholar
• Chen JQ, Papp G, Szodoray P, et al. The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev. 2016;15:1171–1180.
   PubMed Web of Science ®Google Scholar
• Chen XM, Huang QC, Yang SL, et al. Role of micro RNAs in the pathogenesis of rheumatoid arthritis: novel perspectives based on review of the literature. Medicine (Baltimore). 2015;94:e1326.
   PubMed Web of Science ®Google Scholar
• Churov AV, Oleinik EK, Knip M. MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmun Rev. 2015;14:1029–1037.
   PubMed Web of Science ®Google Scholar
• Miao CG, Yang YY, He X, et al. New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery. Cell Signal. 2013;25:1118–1125.
   PubMed Web of Science ®Google Scholar
• Long L, Yu P, Liu Y, et al. Upregulated microRNA-155 expression in peripheral blood mononuclear cells and fibroblast-like synoviocytes in rheumatoid arthritis. Clin Dev Immunol. 2013;2013:296139.
   PubMedGoogle Scholar
• Anaparti V, Smolik I, Meng X, et al. Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects. Arthritis Res Ther. 2017;19:249.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhang Y, Zhu B, et al. Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis. Oncotarget. 2015;6:42557–42568.
   PubMedGoogle Scholar
• Sharma AR, Sharma G, Lee SS, et al. miRNA-regulated key components of cytokine signaling pathways and inflammation in rheumatoid arthritis. Med Res Rev. 2016;36:425–439.
   PubMed Web of Science ®Google Scholar
• Guo Y, Tan LJ, Lei SF, et al. Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis. PLoS Genet. 2010;6:e1000806.
   PubMed Web of Science ®Google Scholar
• Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58:1001–1009.
   PubMed Web of Science ®Google Scholar
• Stanczyk J, Ospelt C, Karouzakis E, et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 2011;63:373–381.
   PubMed Web of Science ®Google Scholar
• Nakasa T, Shibuya H, Nagata Y, et al. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum. 2011;63:1582–1590.
   PubMed Web of Science ®Google Scholar
• Philippe L, Alsaleh G, Suffert G, et al. TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes. J Immunol. 2012;188:454–461.
   PubMed Web of Science ®Google Scholar
• Jansen H, Willenborg C, Lieb W, et al. Rheumatoid arthritis and coronary artery disease: genetic analyses do not support a causal relation. J Rheumatol. 2017;44:4–10.
   PubMedGoogle Scholar
• Jin EH, Shim SC, Kim HG, et al. Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders. Exp Mol Med. 2009;41:354–361.
   PubMed Web of Science ®Google Scholar
• Lopez Herraez D, Martinez-Bueno M, Riba L, et al. Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA class II region. Arthritis Rheum. 2013;65:1457–1467.
   PubMedGoogle Scholar
• Li W, Chang J, Wang S, et al. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Oncotarget. 2015;6:24448–24462.
   PubMedGoogle Scholar
• Khalifa O, Pers YM, Ferreira R, et al. X-Linked miRNAs associated with gender differences in rheumatoid arthritis. Int J Mol Sci. 2016;17:1852.
   Web of Science ®Google Scholar
• Krissansen GW, Yang Y, Mcqueen FM, et al. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:520–530.
   PubMedGoogle Scholar
• Lukamowicz-Rajska M, Mittmann C, Prummer M, et al. MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. Oncotarget. 2016;7:78433–78447.
   PubMed Web of Science ®Google Scholar
• Sun D, Lee YS, Malhotra A, et al. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res. 2011;71:1313–1324.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Pellatt AJ, Lee FY, et al. Infrequently expressed miRNAs influence survival after diagnosis with colorectal cancer. Oncotarget. 2017;8:83845–83859.
   PubMedGoogle Scholar
• De La Rica L, Garcia-Gomez A, Comet NR, et al. NF-kappaB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation. Genome Biol. 2015;16:2.
   PubMed Web of Science ®Google Scholar
• Shor B, Gibbons JJ, Abraham RT, et al. Targeting mTOR globally in cancer: thinking beyond rapamycin. Cell Cycle. 2009;8:3831–3837.
   PubMed Web of Science ®Google Scholar
• Baselga J. Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer. Oncologist. 2011;16(Suppl 1):12–19.
   PubMed Web of Science ®Google Scholar
• Sudarsanam S, Johnson DE. Functional consequences of mTOR inhibition. Curr Opin Drug Discovery Dev. 2010;13:31–40.
   PubMedGoogle Scholar
• Malemud CJ. The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? Future Med Chem. 2015;7:1137–1147.
   PubMed Web of Science ®Google Scholar
• Yang Z, Fujii H, Mohan SV, et al. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med. 2013;210:2119–2134.
   PubMed Web of Science ®Google Scholar
• Laragione T, Gulko PS. mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Mol Med. 2010;16:352–358.
   PubMed Web of Science ®Google Scholar
• Jones RG, Pearce EJ. MenTORing immunity: mTOR signaling in the development and function of tissue-resident immune cells. Immunity. 2017;46:730–742.
   PubMed Web of Science ®Google Scholar
• De Smedt E, Maes K, Verhulst S, et al. Loss of RASSF4 expression in multiple myeloma promotes RAS-driven malignant progression. Cancer Res. 2018;78(5):1155–1168.
   PubMedGoogle Scholar
• Han Y, Dong Q, Hao J, et al. RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion. Tumour Biol. 2016;37:4865–4871.
   PubMedGoogle Scholar
• Guo W, Dong Z, Guo Y, et al. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma. Mol Carcinog. 2016;55:1655–1666.
   PubMed Web of Science ®Google Scholar
• Chandler RL, Brennan J, Schisler JC, et al. ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. Mol Cell Biol. 2013;33:265–280.
   PubMed Web of Science ®Google Scholar
• Wurster AL, Pazin MJ. BRG1-mediated chromatin remodeling regulates differentiation and gene expression of T helper cells. Mol Cell Biol. 2008;28:7274–7285.
   PubMed Web of Science ®Google Scholar
• Chandler RL, Damrauer JS, Raab JR, et al. Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun. 2015;6:6118.
   PubMed Web of Science ®Google Scholar
• Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012;44:694–698.
   PubMed Web of Science ®Google Scholar
• Jones S, Wang TL, Ie M S, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010;330:228–231.
   PubMed Web of Science ®Google Scholar
• Buglioni S, Melucci E, Sperati F, et al. The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression. Oncoimmunology. 2018;7:e1457602.
   PubMed Web of Science ®Google Scholar
• Saleh MA, Mcmaster WG, Wu J, et al. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest. 2015;125:1189–1202.
   PubMed Web of Science ®Google Scholar
• Devalliere J, Charreau B. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol. 2011;82:1391–1402.
   PubMed Web of Science ®Google Scholar
• Bandola J, Richter C, Ryser M, et al. Neurotrophin receptor p75NTR regulates immune function of plasmacytoid dendritic cells. Front Immunol. 2017;8:981.
   PubMed Web of Science ®Google Scholar
• Virchow JC, Julius P, Lommatzsch M, et al. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med. 1998;158:2002–2005.
   PubMed Web of Science ®Google Scholar
• Copray S, Kust B, Emmer B, et al. Deficient p75 low-affinity neurotrophin receptor expression exacerbates experimental allergic encephalomyelitis in C57/BL6 mice. J Neuroimmunol. 2004;148:41–53.
   PubMed Web of Science ®Google Scholar
• Anand P, Terenghi G, Warner G, et al. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med. 1996;2:703–707.
   PubMed Web of Science ®Google Scholar
• Lai NS, Yu HC, Tung CH, et al. The role of aberrant expression of T cell miRNAs affected by TNF-alpha in the immunopathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19:261.
   PubMed Web of Science ®Google Scholar
• Houtman M, Shchetynsky K, Chemin K, et al. T cells are influenced by a long non-coding RNA in the autoimmune associated PTPN2 locus. J Autoimmun. 2018;90:28–38.
   PubMed Web of Science ®Google Scholar